Patients Coming Off Anti-Obesity Injections Put On Pounds at a Quadrupled Rate Than People Using Diet and Exercise

Illustration of pharmaceutical syringe and scale
Obesity treatment involves ongoing approaches.

A recent study indicates that people who stop using popular slimming jabs like semaglutide or tirzepatide may regain reduced body mass far faster than those who stop conventional lifestyle regimens.

Published data in a major medical journal shows that while overweight people frequently drop about a fifth of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month once they quit.

"People purchasing such drugs need to be cognizant of the risk of quick rebound weight gain when the therapy is stopped," warns researcher Dr. Susan Jebb.

That rate of recovery suggests a reversion to starting weight within about one and a half years.

Weighing Approaches

The research, which reviewed dozens of studies involving over 9,000 of patients, contrasted the results of GLP-1 agonists with other pills.

Scientists note that people who shed pounds through diet and exercise typically experience a slower creep back—approximately 100 grams monthly—post-intervention.

Explaining the Fast Regain

Nutrition scientists believe the mode of action of the injections is key to understanding the accelerated regain.

These medications copy a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of GLP-1 levels far above than normal may cause the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication results in hunger is unsuppressed, making excessive eating much more probable."

An Ongoing Condition?

Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.

A number of clinicians contend that, due to the high risk of weight regain, the treatment is often long-term.

This view is echoed by drug manufacturers, who say that the results "emphasize the persistent character of obesity," akin to managing conditions like high blood pressure.

Patient Accounts

Users who have come off the medication describe a intense return of hunger.

"I experienced a switch flipping and you're instantly extremely hungry," recalled one woman.

The struggle is exacerbated if patients have not developed lasting lifestyle or habit modifications during treatment.

Significant Interest

Figures suggest that millions of people in the UK have used these injections in the last 12 months, with interest remaining high.

  • Use is greater among females than males.
  • The 40s and 50s age group shows the highest level of interest.
  • Many obtain the medications through private prescriptions rather than public health services.

In conclusion, experts emphasize that while these medications are potent tools for shedding pounds, they are not a permanent cure and lasting health benefits hinges on integrated lifestyle changes.

Michael Gomez
Michael Gomez

A tech journalist with a passion for exploring emerging digital trends and their impact on modern society.